
Plasmodium yoelii is a rodent parasite commonly used as a model to study malaria infection. It is the preferred model parasite for liver-stage immunological studies and is also widely used to study hepatocyte, erythrocyte and mosquito infection. We have generated a P. yoelii yoelii 17XNL line that is stably transfected with the green fluorescent protein (gfp) gene. This parasite line constitutively expresses high levels of GFP during the complete parasite life cycle including liver, blood and mosquito stages. These fluorescent parasites can be used in combination with fluorescence activated cell sorting or live microscopy for a wide range of experimental applications.
Life Cycle Stages, Erythrocytes, Green Fluorescent Proteins, Drug Resistance, Gene Expression Regulation, Developmental, Plasmodium yoelii, Flow Cytometry, Transfection, Insect Vectors, Malaria, Antimalarials, Disease Models, Animal, Mice, Pyrimethamine, Liver, Anopheles, Animals
Life Cycle Stages, Erythrocytes, Green Fluorescent Proteins, Drug Resistance, Gene Expression Regulation, Developmental, Plasmodium yoelii, Flow Cytometry, Transfection, Insect Vectors, Malaria, Antimalarials, Disease Models, Animal, Mice, Pyrimethamine, Liver, Anopheles, Animals
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 46 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
